Back to News
Market Impact: 0.65

Nomura initiates Bumi Resources Minerals stock with Buy rating on gold assets

NMR
Company FundamentalsAnalyst InsightsCommodities & Raw MaterialsCorporate EarningsCorporate Guidance & OutlookM&A & Restructuring
Nomura initiates Bumi Resources Minerals stock with Buy rating on gold assets

Nomura/Instinet initiated coverage on Bumi Resources Minerals (BRMS:IJ) with a Buy rating and a IDR600.00 price target, highlighting the company as a significant junior gold and copper asset play with substantial resources. The firm projects BRMS will achieve a 57% earnings CAGR and approximately 32% gold production CAGR between 2025-2028, driven by the commissioning of new processing plants and underground mining development. This positive outlook follows the Salim Group's 2021 majority acquisition, which secured financing for the company's operational expansion.

Analysis

Nomura/Instinet has initiated coverage on Bumi Resources Minerals (BRMS:IJ) with a 'Buy' rating and a price target of IDR600.00, framing the company as a key junior mining play with significant gold and copper resources. The firm's bullish thesis is underpinned by BRMS's substantial assets, including 12.4 million ounces of gold and 1.9 million tonnes of copper, and highlights the high quality of its flagship Citra Palu Mineral project, which boasts a gold grade of 3.5 grams per tonne. Critically, Nomura projects a potent growth trajectory, forecasting a 57% compound annual growth rate (CAGR) in earnings and a 32% CAGR in gold production between 2025 and 2028. This growth is expected to be driven by the commissioning of four gold processing plants, with a combined input capacity of 10,500 tons per day, and the development of underground mining operations. The financial viability of this expansion was secured following the Salim Group's acquisition of a majority stake in 2021, which de-risks the company's growth plan from a financing perspective.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo